Quantitative stratification of diffuse parenchymal lung diseases

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Raghunath, Sushravya ^a   Rajagopalan, Srinivasan ^a   Karwoski, Ronald A ^a   Maldonado, Fabien ^b   Peikert, Tobias ^b   Moua, Teng ^b   Ryu, Jay H ^b   Bartholmai, Brian J ^b   Robb, Richard A ^a  

^a MAYO GRADUATE SCHOOL   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DIFFUSE PARENCHYMAL LUNG DISEASE; DISEASE CLASSIFICATION; DISEASE SEVERITY; HUMAN; LUNG DISEASE; MAJOR CLINICAL STUDY; PATIENT SELECTION; PROGNOSIS; QUANTITATIVE ANALYSIS; REPRODUCIBILITY; COMPUTER ASSISTED DIAGNOSIS; DIFFERENTIAL DIAGNOSIS; IMAGE PROCESSING; LUNG; LUNG DISEASES, INTERSTITIAL; LUNG FUNCTION TEST; PATHOLOGY; PATHOPHYSIOLOGY;

DIAGNOSIS, DIFFERENTIAL; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; IMAGE PROCESSING, COMPUTER-ASSISTED; LUNG; LUNG DISEASES, INTERSTITIAL; RESPIRATORY FUNCTION TESTS; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84899790864     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0093229     Document Type: Article

References (39)

1. Olson AL, Swigris JJ, Lezotte DC, Norris JM, Wilson CG, et al. (2007) Mortality from pulmonary fibrosis increased in the United States from 1992 to 2003. American Journal of Respiratory and Critical Care Medicine 176: 277-284. (Pubitemid 47195878)
2. Mannino DM, Buist AS (2007) Global burden of COPD: risk factors, prevalence, and future trends. Lancet 370: 765-773. (Pubitemid 47321908)
3. Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, et al. (2011) An official ATS/ERS/JRS/ALAT statement: idiopathic pulmonary fibrosis: evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 183: 788-824.
4. Travis WD, Costabel U, Hansell DM, King TE, Jr., Lynch DA, et al. (2013) An official American Thoracic Society/European Respiratory Society statement: Update of the international multidisciplinary classification of the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 188: 733-748.
5. Hansell DM (2013) Classification of diffuse lung diseases: why and how. Radiology 268: 628-640.
6. Trusheim MR, Berndt ER, Douglas FL (2007) Stratified medicine: strategic and economic implications of combining drugs and clinical biomarkers. Nature Reviews Drug Discovery 6: 287-293. (Pubitemid 46505879)
7. Cesuroglu T, van Ommen B, Malats N, Sudbrak R, Lehrach H, et al. (2012) Public health perspective: from personalized medicine to personal health. Personalized Medicine 9: 115-119.
8. Hayhurst MD, MacNee W, Flenley DC, Wright D, McLean A, et al. (1984) Diagnosis of pulmonary emphysema by computerised tomography. Lancet 2: 320-322. (Pubitemid 14054822)
9. Lynch DA, Travis WD, Muller NL, Galvin JR, Hansell DM, et al. (2005) Idiopathic interstitial pneumonias: CT features. Radiology 236: 10-21. (Pubitemid 40861695)
10. Xaubet A, Agusti C, Luburich P, Roca J, Monton C, et al. (1998) Pulmonary function tests and CT scan in the management of idiopathic pulmonary fibrosis. American journal of respiratory and critical care medicine 158: 431-436. (Pubitemid 28378169)
11. Akira M, Inoue Y, Kitaichi M, Yamamoto S, Arai T, et al. (2009) Usual Interstitial Pneumonia and Nonspecific Interstitial Pneumonia with and without Concurrent Emphysema: Thin-Section CT Findings. Radiology 251: 271-279.
12. Mooney JJ, Elicker BM, Urbania TH, Agarwal MR, Ryerson CJ, et al. (2013) Radiographic Fibrosis Score Predicts Survival in Hypersensitivity Pneumonitis. Chest 144: 586-592.
13. Flaherty KR, Mumford JA, Murray S, Kazerooni EA, Gross BH, et al. (2003) Prognostic implications of physiologic and radiographic changes in idiopathic interstitial pneumonia. American Journal of Respiratory and Critical Care Medicine 168: 543-548. (Pubitemid 37088596)
14. MacDonald SL, Rubens MB, Hansell DM, Copley SJ, Desai SR, et al. (2001) Nonspecific Interstitial Pneumonia and Usual Interstitial Pneumonia: Comparative Appearances at and Diagnostic Accuracy of Thin-Section CT1. Radiology 221: 600-605. (Pubitemid 33101748)
15. Bartholmai BJ, Raghunath S, Karwoski RA, Moua T, Rajagopalan S, et al. (2013) Quantitative computed tomography imaging of interstitial lung diseases. J Thorac Imaging 28: 298-307.
16. Maldonado F, Moua T, Rajagopalan S, Karwoski RA, Raghunath S, et al. (2014) Automated quantification of radiological patterns predicts survival in idiopathic pulmonary fibrosis. European Respiratory Journal 43: 204-212.
17. Uppaluri R, Hoffman EA, Sonka M, Hunninghake GW, McLennan G (1999) Interstitial lung disease - A quantitative study using the adaptive multiple feature method. American Journal of Respiratory and Critical Care Medicine 159: 519-525. (Pubitemid 29084875)
18. Xu Y, Sonka M, McLennan G, Guo J, Hoffman EA (2006) MDCT-based 3-D texture classification of emphysema and early smoking related lung pathologies. Medical Imaging, IEEE Transactions on 25: 464-475.
19. Castaldi PJ, San Jose Estepar R, Mendoza CS, Hersh CP, Laird N, et al. (2013) Distinct quantitative computed tomography emphysema patterns are associated with physiology and function in smokers. Am J Respir Crit Care Med 188: 1083-1090.
20. Kim SS, Seo JB, Lee HY, Nevrekar DV, Forssen AV, et al. (2013) Chronic obstructive pulmonary disease: lobe-based visual assessment of volumetric CT by Using standard images - comparison with quantitative CT and pulmonary function test in the COPDGene study. Radiology 266: 626-635.
21. Gietema HA, Muller NL, Fauerbach PV, Sharma S, Edwards LD, et al. (2011) Quantifying the extent of emphysema: factors associated with radiologists' estimations and quantitative indices of emphysema severity using the ECLIPSE cohort. Acad Radiol 18: 661-671.
22. Sullivan DC (2008) Imaging as a quantitative science. Radiology 248: 328-332.
23. Celli BR, Cote CG, Marin JM, Casanova C, Montes de Oca M, et al. (2004) The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N Engl J Med 350: 1005-1012. (Pubitemid 38269277)
24. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS, et al. (2001) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 163: 1256-1276. (Pubitemid 32378468)
25. Jones PW, Quirk FH, Baveystock CM, Littlejohns P (1992) A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 145: 1321-1327.
26. Frey BJ, Dueck D (2007) Clustering by passing messages between data points. Science 315: 972-976. (Pubitemid 46281181)
27. CLARKE KR (1993) Non-parametric multivariate analyses of changes in community structure. Australian journal of ecology 18: 117-143.
28. Ley B, Ryerson CJ, Vittinghoff E, Ryu JH, Tomassetti S, et al. (2012) A multidimensional index and staging system for idiopathic pulmonary fibrosis. Ann Intern Med 156: 684-691.
29. Vestbo J, Hurd SS, Agusti AG, Jones PW, Vogelmeier C, et al. (2013) Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 187: 347-365.
30. Raghunath S, Rajagopalan S, Karwoski RA, Larson AG, Bartholmai BJ, et al. (2012) Detail-on-demand visualization for lean understanding of lung abnormalities. Stud Health Technol Inform 173: 362-368.
31. Luppi F, Spagnolo P, Cerri S, Richeldi L (2012) The big clinical trials in idiopathic pulmonary fibrosis. Curr Opin Pulm Med 18: 428-432.
32. Lederer DJ (2013) Clinical trials in idiopathic pulmonary fibrosis: a framework for moving forward. European Respiratory Journal 42: 1442-1448.
33. Pellegrino R, Viegi G, Brusasco V, Crapo RO, Burgos F, et al. (2005) Interpretative strategies for lung function tests. Eur Respir J 26: 948-968. (Pubitemid 41632054)
34. Ryerson CJ, Hartman T, Elicker BM, Ley B, Lee JS, et al. (2013) Clinical features and outcomes in combined pulmonary fibrosis and emphysema in idiopathic pulmonary fibrosis. Chest 144: 234-240.
35. Schuster DP (2007) The opportunities and challenges of developing imaging biomarkers to study lung function and disease. Am J Respir Crit Care Med 176: 224-230.
36. Goldin JG (2013) Computed tomography as a biomarker in clinical trials imaging. Journal of thoracic imaging 28: 291-297.
37. Best AC, Meng J, Lynch AM, Bozic CM, Miller D, et al. (2008) Idiopathic Pulmonary Fibrosis: Physiologic Tests, Quantitative CT Indexes, and CT Visual Scores as Predictors of Mortality1. Radiology 246: 935-940.
38. Lynch DA, Godwin JD, Safrin S, Starko KM, Hormel P, et al. (2005) High-resolution computed tomography in idiopathic pulmonary fibrosis: diagnosis and prognosis. American journal of respiratory and critical care medicine 172: 488-493. (Pubitemid 41117395)
39. Dirksen A, Macnee W (2013) The search for distinct and clinically useful phenotypes in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 188: 1045-1046.